Loading data
ABUSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.08 m USD | 6.17 m USD | 18.14 m USD | 39.02 m USD | 10.99 m USD |
| Research and development expense | 25.24 m USD | 54.04 m USD | 73.7 m USD | 84.41 m USD | 65.5 m USD |
| Operating profit | -38.16 m USD | -76.32 m USD | -78.1 m USD | -65.46 m USD | -73.52 m USD |
| Interest expense | — | — | 459 k USD | 1.73 m USD | 2.86 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 4.44 m USD | 0 USD |
| Net income (reported basis) | -33.5 m USD | -69.92 m USD | -72.85 m USD | -69.46 m USD | -76.25 m USD |
| Net income attributable to common shareholders | — | — | — | -69.46 m USD | -88.39 m USD |
| Basic earnings per share | -0.17 USD/share | -0.38 USD/share | -0.44 USD/share | -0.46 USD/share | -0.83 USD/share |
| Diluted earnings per share | -0.17 USD/share | -0.38 USD/share | -0.44 USD/share | -0.46 USD/share | -0.83 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.